Skip to content

Clinical trials

Observational Neoplasms trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Observational Country / region: Saudi Arabia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20101
20121
20152
20161
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Guard Health Affairs2
AstraZeneca1
Children's Oncology Group1
King Fahad Medical City1
King Faisal Specialist Hospital & Research Center1
King Saud University1
Ministry of Health, Saudi Arabia1
Novartis1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms10
Breast Neoplasms1
Carcinoma in Situ1
Cardiovascular Diseases1
Central Nervous System Neoplasms1
Communicable Diseases1
Desmoid Tumors1
Diabetes Mellitus, Type 21
Fallopian Tube Neoplasms1
Ganglioneuroma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.